A detailed history of Sawgrass Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sawgrass Asset Management LLC holds 68,935 shares of ABBV stock, worth $12.4 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares
68,935
Previous 89,201 22.72%
Holding current value
$12.4 Million
Previous $15.3 Million 11.02%
% of portfolio
1.43%
Previous 1.66%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$163.84 - $199.33 $3.32 Million - $4.04 Million
-20,266 Reduced 22.72%
68,935 $13.6 Million
Q2 2024

Jul 18, 2024

SELL
$154.79 - $180.76 $85,753 - $100,141
-554 Reduced 0.62%
89,201 $15.3 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $638,161 - $727,125
-3,993 Reduced 4.26%
89,755 $16.3 Million
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $2.63 Million - $2.97 Million
19,136 Added 25.65%
93,748 $14.5 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $721,786 - $835,573
-5,403 Reduced 6.75%
74,612 $11.1 Million
Q2 2023

Jul 13, 2023

SELL
$132.51 - $164.9 $8.49 Million - $10.6 Million
-64,091 Reduced 44.47%
80,015 $10.8 Million
Q1 2023

May 09, 2023

SELL
$144.61 - $166.54 $540,696 - $622,693
-3,739 Reduced 2.53%
144,106 $23 Million
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $432,633 - $518,841
-3,128 Reduced 2.07%
147,845 $23.9 Million
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $2.2 Million - $2.53 Million
16,413 Added 12.2%
150,973 $20.3 Million
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $11.9 Million - $15.2 Million
-86,782 Reduced 39.21%
134,560 $20.6 Million
Q1 2022

May 18, 2022

BUY
$131.98 - $163.75 $29.2 Million - $36.2 Million
221,342 New
221,342 $35.9 Million
Q4 2021

Feb 03, 2022

SELL
$107.43 - $135.93 $23.8 Million - $30.1 Million
-221,192 Closed
0 $0
Q3 2021

Nov 04, 2021

SELL
$106.4 - $120.78 $4.15 Million - $4.71 Million
-38,965 Reduced 14.98%
221,192 $23.9 Million
Q2 2021

Aug 05, 2021

SELL
$105.21 - $117.21 $8.6 Million - $9.59 Million
-81,785 Reduced 23.92%
260,157 $29.3 Million
Q1 2021

Apr 29, 2021

BUY
$102.3 - $112.62 $3.91 Million - $4.3 Million
38,222 Added 12.58%
341,942 $37 Million
Q4 2020

Jan 22, 2021

SELL
$80.49 - $108.67 $465,071 - $627,895
-5,778 Reduced 1.87%
303,720 $32.5 Million
Q3 2020

Nov 02, 2020

BUY
$85.91 - $100.83 $6.65 Million - $7.8 Million
77,352 Added 33.32%
309,498 $27.1 Million
Q2 2020

Jul 27, 2020

SELL
$73.37 - $98.18 $1.48 Million - $1.98 Million
-20,189 Reduced 8.0%
232,146 $22.8 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $2.84 Million - $4.31 Million
-44,054 Reduced 14.86%
252,335 $19.2 Million
Q4 2019

Feb 10, 2020

SELL
$72.13 - $90.25 $374,787 - $468,939
-5,196 Reduced 1.72%
296,389 $26.2 Million
Q3 2019

Oct 30, 2019

SELL
$62.98 - $75.72 $10.4 Million - $12.5 Million
-165,727 Reduced 35.46%
301,585 $22.8 Million
Q2 2019

Jul 23, 2019

BUY
$65.7 - $83.98 $1.7 Million - $2.17 Million
25,800 Added 5.84%
467,312 $34 Million
Q1 2019

May 07, 2019

BUY
$77.14 - $90.79 $2.5 Million - $2.95 Million
32,458 Added 7.93%
441,512 $35.6 Million
Q4 2018

Feb 01, 2019

BUY
$77.85 - $96.01 $2.19 Million - $2.7 Million
28,134 Added 7.39%
409,054 $37.7 Million
Q3 2018

Nov 19, 2018

BUY
$88.91 - $98.84 $32.1 Million - $35.6 Million
360,671 Added 1781.18%
380,920 $36 Million
Q2 2018

Jul 26, 2018

SELL
$89.78 - $106.23 $26.9 Million - $31.9 Million
-300,000 Reduced 93.68%
20,249 $29.7 Million
Q2 2018

Jul 26, 2018

BUY
$89.78 - $106.23 $810,892 - $959,469
9,032 Added 2.9%
320,249 $29.7 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $6.73 Million - $9.01 Million
-73,090 Reduced 19.02%
311,217 $29.5 Million
Q4 2017

Feb 12, 2018

SELL
$89.56 - $98.21 $18.6 Million - $20.4 Million
-208,100 Reduced 35.13%
384,307 $37.2 Million
Q3 2017

Nov 09, 2017

SELL
$69.85 - $89.22 $6.59 Million - $8.41 Million
-94,275 Reduced 13.73%
592,407 $52.6 Million
Q2 2017

Aug 11, 2017

BUY
N/A
686,682
686,682 $49.8 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sawgrass Asset Management LLC Portfolio

Follow Sawgrass Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawgrass Asset Management LLC with notifications on news.